Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
300760
Rang in Aktien
#827
Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd.... Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. specializes in providing a comprehensive range of medical devices and innovative healthcare solutions. Its extensive portfolio encompasses several key segments. Within patient monitoring and life support, the company manufactures crucial equipment such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, and endoscopes, along with associated accessories. This segment also delivers integrated solutions for emergency care, peri-operative management, critical care, and medical IT systems. For in-vitro diagnostics, Mindray offers sophisticated products including hematology and chemistry analyzers and their reagents, chemiluminescence immunoassay products, hemoglobin systems, flow cytometry instruments, and microplate readers and washers. These are further supported by solutions tailored for coagulation, urinalysis, and microbiology. The company additionally produces advanced medical imaging systems, covering both ultrasound and radiology products, and supplies a dedicated line of veterinary products. Founded in 1991, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. maintains its primary operational base in Shenzhen, People's Republic of China.
Aktienkurs
$24.28
Marktkapitalisierung
$29.42B
Veränderung (1 Tag)
0.15%
Veränderung (1 Jahr)
-23.26%
Land
CN
Handel Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760)
Kategorie
Healthcare
Operative Marge für Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760)
Operative Marge zum October 2026 TTM: 27.58%
Laut den neuesten Finanzberichten und dem Aktienkurs von Shenzhen Mindray Bio-Medical Electronics Co., Ltd. beträgt die aktuelle operative Marge (TTM) 27.58%. Am Ende des Jahres 2023 lag die operative Marge bei 37.42%.
Historie der operativen Marge von Shenzhen Mindray Bio-Medical Electronics Co., Ltd. von 2014 bis 2026
Operative Marge zum Jahresende
| Jahr | Operative Marge | ändert |
|---|---|---|
| 2026 (TTM) | 27.58% | -22.75% |
| 2024 | 35.70% | -4.60% |
| 2023 | 37.42% | 3.40% |
| 2022 | 36.19% | 0.86% |
| 2021 | 35.88% | 1.18% |
| 2020 | 35.46% | 9.14% |
| 2019 | 32.49% | 4.44% |
| 2018 | 31.11% | 20.72% |
| 2017 | 25.77% | 50.26% |
| 2016 | 17.15% | 42.92% |
| 2015 | 12.00% | -22.13% |
| 2014 | 15.41% | 0.00% |
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Operative Marge | Differenz der operativen Marge | Land |
|---|---|---|---|
| 17.03% | -99.38% |
US
|
|
| 17.86% | -99.35% |
IE
|
|
| 22.03% | -99.20% |
US
|
|
| 21.46% | -99.22% |
US
|
|
| 0.00% | - |
DE
|
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.